Basics MIMEDX GROUP INC MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. IPO Date: March 1, 2008 Sector: Healthcare Industry: Biotech Market Cap: $999.94M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 2.50% Avg Daily Range (30 D): $0.13 | 1.83% Avg Daily Range (90 D): $0.14 | 1.82% Institutional Daily Volume Avg Daily Volume: .77M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): .5M Trade Size Avg Trade Size (Sh.): 148 Avg Trade Size (Sh.) (30 D): 86 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 1,913 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $.85M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.53M Avg Closing Trade (30 D): $.77M Avg Closing Trade (90 D): $.84M Avg Closing Volume: 176.51K         News Feb 12, 2025 @ 12:00 PM MediWound Initiates the VALUE Global Phase III Piv... Source: N/A Nov 26, 2024 @ 11:47 AM Chronic Wound Care Market to Expand at a Modest 4.... Source: Globe Newswire Oct 8, 2024 @ 8:01 PM MIMEDX Points to The New York Times Article on the... Source: N/A Oct 1, 2024 @ 8:01 PM MIMEDX Showcases Leading Allograft Portfolio and I... Source: N/A Jun 26, 2024 @ 8:01 PM MIMEDX Announces the Appointment of Kim Moller to ... Source: MiMedx Group, Inc Financials   TTM Q1 2025 Q4 2024 Basic EPS $.27 $.05 $.05 Diluted EPS $.27 $.05 $.05 Revenue $ 352.38M $ 88.21M $ 92.91M Gross Profit $ 288.73M $ 71.65M $ 76M Net Income / Loss $ 40.18M $ 7.02M $ 7.44M Operating Income / Loss $ 53.92M $ 8.25M $ 11.05M Cost of Revenue $ 63.64M $ 16.56M $ 16.91M Net Cash Flow $ 57.94M $ 2.02M $ 15.62M PE Ratio 23.69     Splits Apr 02, 2008:   11:34